PowerVision is trying to fundraise $30 million, having so far brought in $4 million, according to a regulatory filing.
The Belmont, Calif.-based device maker develops and markets fluid-controlled intraocular lens technology. So far, the company has brought in $4 million dollars through an equity sale among 9 unnamed investors. The company has an agreement with the investors for another $16 million, but provided few details in the SEC filing.
The company previously secured funding for its operations from Medtronic (NYSE:MDT) and Johnson & Johnson’s (NYSE:JNJ) development corp.
